Buy Tesamorelin Ipamorelin Blend for Advanced GH Research The Tesamorelin Ipamorelin blend delivers a powerful dual-mechanism approach to growth hormone research. By combining a GHRH analog with a selective growth hormone secretagogue, this peptide stack allows researchers to explore amplified GH signaling in controlled laboratory environments. Scientists use this blend to study growth hormone pulsatility, IGF-1 production, fat metabolism pathways, and regenerative signaling models. What Is Tesamorelin? Tesamorelin is a synthetic analog of growth hormone–releasing hormone (GHRH). It stimulates the pituitary gland to increase endogenous growth hormone production. Researchers study tesamorelin for its effects on IGF-1 levels and fat metabolism pathways, particularly in visceral fat research models. What Is Ipamorelin? Ipamorelin is a selective growth hormone secretagogue that mimics ghrelin activity. It activates the GHS-R1a receptor and promotes growth hormone release without significantly influencing cortisol or prolactin in research settings. Scientists value ipamorelin for its receptor selectivity and clean GH stimulation profile. Why Combine Tesamorelin and Ipamorelin? This blend activates two separate receptors involved in GH release: Tesamorelin → GHRH receptor stimulation Ipamorelin → Ghrelin (GHS-R1a) receptor stimulation By targeting both pathways, researchers can examine synergistic growth hormone release patterns. This dual activation supports studies focused on: Growth hormone pulse amplification IGF-1 regulation Lean tissue signaling Fat metabolism research Recovery and regenerative models The complementary mechanisms make this peptide stack particularly relevant in metabolic and endocrine research protocols. Product Specifications Form: Lyophilized peptide blend Purity: ≥98% (HPLC verified) Blend Ratios: Example 5mg/5mg or 10mg total (varies) Grade: Research grade Storage: 2–8°C before reconstitution Intended Use: Laboratory research only Manufacturers produce each batch under strict quality control conditions to ensure identity, purity, and structural integrity. Certificate of Analysis (COA) Test Parameter Specification Result Test Method Appearance White to off-white lyophilized powder Complies Visual Peptide Identity (Tesamorelin) Conforms to reference standard Confirmed Mass Spectrometry Peptide Identity (Ipamorelin) Conforms to reference standard Confirmed Mass Spectrometry Molecular Weight Conforms to theoretical values Conforms MS Analysis Purity (HPLC) ≥ 98.0% 99.08% HPLC Single Impurity ≤ 1.0% 0.44% HPLC Total Impurities ≤ 2.0% 0.91% HPLC Residual Solvents Within ICH limits Complies GC Bacterial Endotoxins ≤ 0.5 EU/mg < 0.2 EU/mg LAL Test Heavy Metals ≤ 10 ppm < 5 ppm ICP-MS Microbial Limits Meets USP standards Pass Microbial Test Water Content ≤ 8.0% 4.5% Karl Fischer COA Conclusion This batch of Tesamorelin Ipamorelin blend meets established research-grade quality specifications. Analytical testing confirms peptide identity, molecular weight accuracy, and high purity levels above the required ≥98% standard. Impurity levels remain well within acceptable limits, and microbiological testing verifies compliance with USP standards. Residual solvents, endotoxin levels, heavy metals, and water content all fall within validated safety parameters. The manufacturing process maintained strict quality control to preserve structural integrity and peptide stability. Based on the documented analytical results, this batch complies with defined laboratory specifications and is suitable for research use under controlled conditions. Important Notice The Tesamorelin Ipamorelin blend is intended strictly for laboratory research. It is not approved for human consumption or clinical use. Qualified professionals must handle this compound in regulated research environments. 3RD PARTY TESTING This Tesamorelin Ipamorelin peptide blend undergoes rigorous third-party laboratory testing to verify identity, purity, and structural integrity. Every batch is analyzed by accredited labs to ensure ≥98% purity, minimal impurities, and compliance with research-grade standards, providing reliable results for controlled laboratory studies.
